- Home
- TRC vs OABI Comparison
TRC vs OABI Comparison
Compare TRC & OABI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRC
- OABI
- Stock Information
- Founded
- TRC 1843
- OABI 2012
- Country
- TRC United States
- OABI United States
- Employees
- TRC N/A
- OABI N/A
- Industry
- TRC Real Estate
- OABI Biotechnology: Pharmaceutical Preparations
- Sector
- TRC Finance
- OABI Health Care
- Exchange
- TRC Nasdaq
- OABI Nasdaq
- Market Cap
- TRC 455.3M
- OABI 459.1M
- IPO Year
- TRC N/A
- OABI N/A
- Fundamental
- Price
- TRC $15.59
- OABI $3.85
- Analyst Decision
- TRC
- OABI Strong Buy
- Analyst Count
- TRC 0
- OABI 4
- Target Price
- TRC N/A
- OABI $9.00
- AVG Volume (30 Days)
- TRC 89.5K
- OABI 509.5K
- Earning Date
- TRC 11-07-2024
- OABI 11-12-2024
- Dividend Yield
- TRC N/A
- OABI N/A
- EPS Growth
- TRC N/A
- OABI N/A
- EPS
- TRC N/A
- OABI N/A
- Revenue
- TRC $40,118,000.00
- OABI $20,409,000.00
- Revenue This Year
- TRC N/A
- OABI N/A
- Revenue Next Year
- TRC $18.51
- OABI $71.78
- P/E Ratio
- TRC N/A
- OABI N/A
- Revenue Growth
- TRC N/A
- OABI N/A
- 52 Week Low
- TRC $14.80
- OABI $3.56
- 52 Week High
- TRC $19.82
- OABI $6.72
- Technical
- Relative Strength Index (RSI)
- TRC 39.36
- OABI 40.94
- Support Level
- TRC $15.92
- OABI $3.62
- Resistance Level
- TRC $17.46
- OABI $4.19
- Average True Range (ATR)
- TRC 0.46
- OABI 0.23
- MACD
- TRC -0.06
- OABI -0.06
- Stochastic Oscillator
- TRC 3.05
- OABI 18.40
About TRC Tejon Ranch Co
Tejon Ranch Co is a diversified real estate development and agribusiness company committed to responsibly using its land and resources to meet the housing, employment, and lifestyle needs of Californians and create value for its shareholders. It has five segments namely commercial/industrial real estate development, resort/residential real estate development, mineral resources, farming, and ranch operations.
About OABI OmniAb Inc.
OmniAb Inc offers therapeutic antibody discovery technologies. The company focuses on enabling the rapid development of therapeutics by pushing the frontiers of drug discovery technologies. Its technology platform is designed to enable the efficient discovery of high-quality, fully human antibodies for a wide range of diseases. The heart of the OmniAb technology platform is the Biological Intelligence of its proprietary transgenic animals, including OmniRat, OmniMouse, and OmniChicken, that have been genetically modified to generate antibodies with human sequences which are naturally optimized through in vivo affinity maturation.